Lv1
10 积分 2021-11-24 加入
Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis
20小时前
待确认
Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis
26天前
已完结
How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe
1年前
已完结
膳食模式与2型糖尿病的队列研究
1年前
已完结
Cost–effectiveness analysis of serplulimab as first-line treatment for advanced esophageal squamous cell carcinoma
1年前
已完结
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
2年前
已完结
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
3年前
已完结
皖公网安备34019202002308
